Login to Your Account



DEALS AND M&A NEWS

SHANGHAI – HD Biosciences Co. Ltd. has signed an agreement to co-develop drugs with two research centers at Marshall University. The deal was struck after three years of informal collaboration between both sides, and with an eye to entering the clinic in the next two years. The focus of the alliance is to provide innovative medicines for unmet medical needs, particularly cancer and kidney fibrosis, in both China and the U.S.

LONDON – The deals go on for Immunocore Ltd., which has signed Eli Lilly and Co. as the fourth partner in little over a year for its Immtac T-cell receptor technology.
FIFTH TIME THE CHARM?

LONDON – It looks like the fifth time is lucky for Abbvie Inc. after Shire plc agreed to open negotiations on a sale following an increased offer of £53.20 (US$90.98) per share, valuing the company at £31 billion.

More DEALS AND M&A Headlines

Cast Your Vote

Has biotech’s bubble burst?: